[PDF][PDF] Prognostic score including gene mutations in chronic myelomonocytic leukemia
R Itzykson, O Kosmider, A Renneville… - Journal of clinical …, 2013 - researchgate.net
R Itzykson, O Kosmider, A Renneville, V Gelsi-Boyer, M Meggendorfer, M Morabito…
Journal of clinical oncology, 2013•researchgate.netPurpose Several prognostic scoring systems have been proposed for chronic
myelomonocytic leukemia (CMML), a disease in which some gene mutations—including
ASXL1—have been associated with poor prognosis in univariable analyses. We developed
and validated a prognostic score for overall survival (OS) based on mutational status and
standard clinical variables.
myelomonocytic leukemia (CMML), a disease in which some gene mutations—including
ASXL1—have been associated with poor prognosis in univariable analyses. We developed
and validated a prognostic score for overall survival (OS) based on mutational status and
standard clinical variables.
Purpose
Several prognostic scoring systems have been proposed for chronic myelomonocytic leukemia (CMML), a disease in which some gene mutations—including ASXL1—have been associated with poor prognosis in univariable analyses. We developed and validated a prognostic score for overall survival (OS) based on mutational status and standard clinical variables.
researchgate.net